The Foundation awards Oregon Health & Science University (and other institutions globally) an $8,800 Supplement for their Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.
An additional $8,800 was granted to Oregon Health & Science University to include John Hopkins University in this DIPG Preclinical study first supported by The Foundation in November 2011.
(See below for further information)
